AI-generated summary
The authors studied whether photobiomodulation (light therapy) applied to human umbilical cord mesenchymal stem cells could change microglia, immune cells in the brain, in a cell model and an LPS-induced mouse model. They report that these pretreated stem cells promoted the anti-inflammatory M2 microglial phenotype and improved cognitive function in mice, associated with reduced Notch signaling. The abstract does not report sample sizes, and the findings come from in vitro and animal experiments.
- Who or what was studied
- In vitro microglial inflammation model and LPS-induced mouse model
- Limits stated in the abstract
- The abstract reports only in vitro and mouse experiments and does not state sample sizes or the light parameters used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Neuroinflammation, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.